IP Library Granted Patent US 11,572,551
Granted Patent B2
US 11,572,551 · App. 17/043,339 · Granted Feb 7, 2023

Hydrolase and method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid using same

Inventors: Toyokazu Yoshida (Gifu, JP); Koichi Ishida (Gifu, JP); Ryoma Miyake (Tokyo, JP); Takanobu Iura (Tokyo, JP); Hiroshi Kawabata (Tokyo, JP)
Assignee: API CORPORATION
C12N9/18C12P7/62C12P41/00C12Y301/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,572,551
App. No.
17/043,339
Granted
Feb 7, 2023
Kind
B2
Abstract

The present invention provides a novel hydrolase that can industrially produce optically highly pure (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid with high efficiency at low costs, and a production method using the hydrolase.

Claims (40)

1. A hydrolase consisting of a variant of the amino acid sequence shown in SEQ ID NO: 2 with at least 5 and up to 50 amino acid substitutions, deletions, insertions, and/or additions.

2. A nucleic acid encoding the hydrolase according to claim 1 .

3. The nucleic acid according to claim 2 , wherein the aforementioned nucleic acid comprises a base sequence of the base sequence shown in SEQ ID NO: 1, with at least 15 and up to 150 nucleotide substitutions, deletions, insertions and/or additions.

4. A method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid, comprising bringing a hydrolase, a microorganism or cell having an ability to produce the hydrolase, and/or a culture solution containing the hydrolase into contact with dialkyl 2-vinylcyclopropane-1,1-dicarboxylic acid, wherein the hydrolase comprises a polypeptide of the following (a), (b), (c), or (d):

(a) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 2;

(b) a polypeptide having an amino acid sequence resulting from the deletion, insertion, substitution, and/or addition of one to 5 amino acids in the amino acid sequence shown in SEQ ID NO: 2, and an activity to catalyze the reaction shown in the formula (1)

wherein R is an alkyl group having 1-6 carbon atoms in the formula (1), and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%;

(c) a polypeptide consisting of an amino acid sequence with not less than 95% of sequence identity with the amino acid sequence shown in SEQ ID NO: 2, and an activity to catalyze the reaction shown in the above-mentioned formula (1), wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%;

(d) a polypeptide consisting of an amino acid sequence with not less than 90% of sequence identity with the amino acid sequence shown in SEQ ID NO: 2, wherein the aforementioned amino acid sequence comprises

(i) 5 consecutive residues DATRG corresponding to residues 75-79 of SEQ ID NO: 2;

(ii) 4 consecutive residues PYGF corresponding to residues 133-136 of SEQ ID NO: 2;

(iii) 4 consecutive residues NWPG corresponding to residues 224-227 of SEQ ID NO: 2; and/or

(iv) 5 consecutive residues PGWPG corresponding to residues 287-291 of SEQ ID NO: 2, and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%.

5. The production method according to claim 4 , wherein R in the formula (1) is an ethyl group.

6. A recombinant vector comprising the nucleic acid according to claim 2 .

7. A transformant comprising the recombinant vector according to claim 6 .

8. The production method according to claim 4 , wherein the microorganism or cell is a microorganism or cell transformed with a nucleic acid comprising a base sequence of the following (e), (f), (g), or (h):

(e) the base sequence shown in SEQ ID NO: 1;

(f) a nucleic acid consisting of a base sequence resulting from the substitution, deletion, and/or addition of one to 15 bases in the base sequence shown in SEQ ID NO: 1, and encoding a polypeptide having an activity to catalyze the reaction shown in the formula (1)

wherein R is an alkyl group having 1-6 carbon atoms in the formula (1), and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%;

(g) a nucleic acid consisting of a base sequence having not less than 98% of sequence identity with the base sequence shown in SEQ ID NO: 1, and encoding a polypeptide having an activity to catalyze the reaction shown in the above-mentioned formula (1);

(h) a nucleic acid having a base sequence that hybridizes with a complementary strand of the base sequence shown in SEQ ID NO: 1 under the condition of washing once at 60° C., 1×SSC, and 0.1% SDS, and encoding a polypeptide having an activity to catalyze the reaction shown in the above-mentioned formula (1), and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%.

9. A recombinant vector comprising the nucleic acid according to claim 3 .

10. A method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid, comprising bringing a treated product of a microorganism or cell having the ability to produce a hydrolase into contact with dialkyl 2-vinylcyclopropane-1,1-dicarboxylic acid, wherein the hydrolase comprises a polypeptide of the following (a), (b), (c), or (d):

(a) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 2;

(b) a polypeptide having an amino acid sequence resulting from the deletion, insertion, substitution, and/or addition of one to 5 amino acids in the amino acid sequence shown in SEQ ID NO: 2, and an activity to catalyze the reaction shown in the formula (1)

wherein R is an alkyl group having 1-6 carbon atoms in the formula (1), and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%;

(c) a polypeptide consisting of an amino acid sequence with not less than 95% of sequence identity with the amino acid sequence shown in SEQ ID NO: 2, and an activity to catalyze the reaction shown in the above-mentioned formula (1), wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%;

(d) a polypeptide consisting of an amino acid sequence with not less than 90% of sequence identity with the amino acid sequence shown in SEQ ID NO: 2, wherein the aforementioned amino acid sequence comprises:

(i) 5 consecutive residues DATRG corresponding to residues 75-79 of SEQ ID NO: 2;

(ii) 4 consecutive residues PYGF corresponding to residues 133-136 of SEQ ID NO: 2;

(iii) 4 consecutive residues NWPG corresponding to residues 224-227 of SEQ ID NO: 2; and/or

(iv) 5 consecutive residues PGWPG corresponding to residues 287-291 of SEQ ID NO: 2, and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%.

11. The production method according to claim 10 , wherein R in the formula (1) is an ethyl group.

12. The production method according to claim 10 , wherein the microorganism or cell is a microorganism or cell transformed with a nucleic acid comprising a base sequence of the following (e), (f), (g), or (h):

(e) the base sequence shown in SEQ ID NO: 1;

(f) a nucleic acid consisting of a base sequence resulting from the substitution, deletion, and/or addition of one to 15 bases in the base sequence shown in SEQ ID NO: 1, and encoding a polypeptide having an activity to catalyze the reaction shown in the formula (1)

wherein R is an alkyl group having 1-6 carbon atoms in the formula (1), and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%;

(g) a nucleic acid consisting of a base sequence having not less than 98% of sequence identity with the base sequence shown in SEQ ID NO: 1, and encoding a polypeptide having an activity to catalyze the reaction shown in the above-mentioned formula (1);

(h) a nucleic acid having a base sequence that hybridizes with a complementary strand of the base sequence shown in SEQ ID NO: 1, under the condition of washing once at 60° C., 1×SSC, and 0.1% SDS, and encoding a polypeptide having an activity to catalyze the reaction shown in the above-mentioned formula (1), and wherein the production ratio of Syn isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid in the formula (II) to Anti isomer of the 1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid is equal to or less than 0.2%.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2020
From: YOSHIDA, TOYOKAZU; ISHIDA, KOICHI; MIYAKE, RYOMA; IURA, TAKANOBU; KAWABATA, HIROSHI
To: API CORPORATION
Reel/Frame 054198/0987 →
Priority Claims (1)
JP JP2018-070188 · Mar 30, 2018 · national
Continuity (1)
Related Publication 20210024905A1 · Jan 28, 2021